Experimental Hematology and Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 17.5 | Q1 | 96.1% | 4.126 | Q1 | 98.6% |
| 2024 | 13.5 | Q1 | 94.9% | 3.092 | Q1 | 97.8% |
| 2023 | 9.4 | Q1 | 88.1% | 2.384 | Q1 | 96.7% |
| 2022 | 10.9 | Q1 | 88.5% | 1.908 | Q1 | 95.3% |
| 2021 | 8.6 | Q1 | 84.9% | 1.301 | Q1 | 91.2% |
| 2020 | — | — | 1.223 | Q1 | 89.3% | |
| 2019 | — | — | 0.941 | Q2 | 84.3% | |
| 2018 | — | — | 0.988 | Q2 | 83.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2162-3619
country
GBcoverage
2012-2026